The Pioneer of the
Pharmaceutical Industry in India
Dr.Kallam Anji Reddy,58, is the founder Chairman of Dr. Reddy's Group of Companies and is a pioneer & leader in Bulk Drugs and Pharmaceutical Industry in India.
Dr. Reddy has done his B.Sc from Andhra Christian College, Guntur and has completed his
B.Sc. (Tech) in Pharmaceutical Science from Bombay University and Ph.D. from National Chemical Laboratory,
Pune. Dr. Reddy had six years experience in "Indian Drugs &
Pharmaceuticals Ltd." (IDPL) in the manufacture and implementation of new technologies in bulk drugs. After coming out from IDPL in 1973, Dr.Reddy pioneered a number of bulk drugs for the first time in the country. The consumption of many front-line basic drugs has gone up several folds because of the successful indigenous development of technologies by his group of companies. Before starting his own group of companies, Dr. Reddy has pioneered the development and production of Metronidazole (1976
MD-Uniloids) and Sulphamethoxazole (1981 MD-Standard Organics Ltd).
|In 1984, he set up Dr. Reddy's Laboratories Ltd and Cheminor Drugs Limited. Starting with a modest turnover of Rs.1.5 crore in 1985, the group registered a combined turnover of Rs.984 crore in the year 2000-2001.
His mission is clear as stated in one of his many lectures.' The
Patent Act 1970 has enabled the industry to introduce newer and better medicines in the country without going through heavy investments in Research and
Development. This opportunity must be utilized by the industry not to make enormous profits for themselves; but to bring these drugs to the masses of India at affordable prices".
Dr.Reddy's Research Foundation
(DRF), established in 1992, the research arm of Dr.Reddy's Group is the first organization in Indian Pharmaceutical Industry to take up basic research. Since its inception, DRF has filed a total of 61 patents with the USPTO and 42 with the PCT, for its discoveries in Cancer, Diabetes, Ulcer and Bacterial infections. It has been granted 21 patents by the USPTO so far.
Dr. Reddy's Laboratories has licensed two of its discoveries in the anti-diabetes field for co-development to Novo Nordisk of Denmark, a world leader in diabetic care, in return for an upfront payment, milestone payments and royalties. Dr. Reddy's has recently out-licensed DRF 4158, an insulin sensitiser in type 2 diabetes, in return for up to US $ 55 million in upfront and milestone payments for specific clinical and regulatory endpoints, as well as royalties. Dr. Reddy's also enjoys the distinction of being the first Asia Pacific (non-Japanese) pharmaceutical company to list on NYSE.
These achievements of Dr. Anji Reddy and his group have been recognized by the Government. Dr.Reddy has been a member of Drug Technical Advisory Board and Pharmaceutical Council of India. Dr.Reddy has also served as Chairman of Andhra Pradesh Industrial Development Corporation (A.P.I.D.C.). Dr.Reddy had been the President of Indian Pharmaceutical Congress Association, 1992. Dr. Reddy is a Member of the Board of Trade. He is the Chairman of FICCI (R&D) Committee. Dr. Reddy was recently nominated as Member of the Task Force on Pharmaceuticals and Knowledge-based industries by the Prime Minister.
Dr.Reddy has received several
awards. Some of the notable awards are:
SIR P C RAY AWARD (TWICE) - by Indian Chemical Manufacturers' Association for development of indigenous technology (1984 & 1992).
INDIAN CHEMICAL MANUFACTURERS' ASSOCIATION'S EXPORT AWARD for successfully penetrating the international market with a sophisticated drug like Methyldopa (1986)
MANAGER OF THE YEAR 1987 - by Hyderabad Management Association for outstanding managerial achievements and contributions made to the Society.
PROF. NAYUDAMMA MEMORIAL GOLD MEDAL AWARD - for being the Outstanding Technologist of Andhra Pradesh for the year 1989 given by
A.P. Academy of Sciences.
LIFE-TIME ACHIEVEMENT AWARD - for Research and Industry, conferred by ANACON (Indian Analytical Instrument Association) for the year 1997.
FAPA-ISHIDATE AWARD - given to an outstanding Asian Pharmacist excelling in Pharmaceutical Research by the Federation of Asian Pharmaceutical Associations
(FAPA) in the year 1998.
PRAGNA PURASKAR - 1998 Annual Award given by Pragna Bharati (Andhra Pradesh) for his outstanding national contribution to the field of Pharmaceutical R&D.
ACHIEVER OF THE YEAR AWARD - from CHEMTECH Foundation in November 2000 for his outstanding contribution to the nation for pioneering the introduction of affordable medicines to the people of India.
PADMASHREE AWARD - In March, 2001 by the President of India for his distinguished service in the field of Trade and Economic Activity/Industry.
Dr. Reddy had led a delegation of CHEMEXCIL, sponsored by Government of India, to study the export opportunities, to Europe, USA and Japan and submitted a report in 1985.
Dr.Reddy has given Key Note addresses in various pharmaceutical meets at different places like Madras, Bombay, Calcutta and Presidential Address at IPCA, Bangalore. These lectures contain a wealth of information and are considered to be reference papers for many bulk drug manufacturers.
Dr.Reddy has been encouraging cultural and educational programs in the State by donating to and sponsoring such programs from time to time. Critically aware of his own responsibility to society, he established Dr. Reddy's Foundation for Human and Social Development to act as a catalyst in the management of change. Through this social responsibility of business programme, the first of its kind in Andhra Pradesh, Dr. Reddy has promoted investments in entrepreneurship development through micro-finance and touched the lives of thousands of rural women and their families and hundreds of street children in the twin cities of
Hyderabad and Secunderabad.
Profile on Dr. Anji Reddy
Reachout's Previous Businessman of the Year 1999 - 2000.
Reachout's News Bureau